Motor neurons are nerve cells that control our muscles by sending signals from the brain and spinal cord out to the body. In ...

They were designed to treat diabetes, then prescribed for weight loss, and now—as researchers are finding—they might hold the ...

Biogen has emerged as a potential front-runner at the Cannes Lions International Festival of Creativity, snagging four spots ...

Biogen Inc. (NASDAQ:BIIB) is one of the 11 most profitable NASDAQ stocks to buy now. On June 12, UCB and Biogen presented ...

The 12-month price targets, analyzed by analysts, offer insights with an average target of $190.82, a high estimate of ...

Looking at licensing deals struck in the past 10 years, Jefferies found that many Big Pharmas do not ultimately follow ...

a Biogen drug approved to treat amyotrophic lateral sclerosis. Medicare Advantage, or MA, plans are a privatized form of Medicare, the federal health insurance program for people aged 65 or older.

Medicare Advantage plans must cover Biogen’s (NASDAQ:BIIB) drug Qalsody for the treatment of ALS, according to a report. The U.S. Centers for Medicare & Medicaid Services has directed insurance ...

Another selling point, according to Tong, was the precedent set by Biogen’s Qalsody ... slow the functional decline associated with ALS. The drug was still approved last year, though, due ...